• Impact of adjusting for the reciprocal relationship between maternal weight and free thyroxine during early pregnancy.

      Haddow, James E; Craig, Wendy Y; Palomaki, Glenn E; Neveux, Louis M; Lambert-Messerlian, Geralyn; Canick, Jacob A; Malone, Fergal D; D'Alton, Mary E; Division of Medical Screening and Special Testing, Women and Infants Hospital, Alpert Medical School of Brown University, Providence, Rhode Island 02903, USA. jhaddow@ipmms.org (2013-02)
      Among euthyroid pregnant women in a large clinical trial, free thyroxine (FT4) measurements below the 2.5th centile were associated with a 17 lb higher weight (2.9 kg/m(2)) than in the overall study population. We explore this relationship further.
    • Implications of High Free Thyroxine (FT4) concentrations in euthyroid pregnancies: the FaSTER trial.

      Haddow, James E; Craig, Wendy Y; Neveux, Louis M; Haddow, Hamish R M; Palomaki, Glenn E; Lambert-Messerlian, Geralyn; Malone, Fergal D; D'Alton, Mary E; Rotunda Hospital (2014-06)
      Lower birth weight has been reported in conjunction with high maternal free T4 (FT4) in euthyroid pregnancies, raising concerns for suboptimal outcomes.
    • Influence of maternal BMI on genetic sonography in the FaSTER trial.

      Aagaard-Tillery, Kjersti M; Flint Porter, T; Malone, Fergal D; Nyberg, David A; Collins, Jamie; Comstock, Christine H; Hankins, Gary; Eddleman, Keith; Dugoff, Lorraine; Wolfe, Honor M; et al. (2010-01)
      We sought to evaluate the influence of maternal body mass index (BMI) on sonographic detection employing data from the FaSTER trial.
    • Preconceptional folate supplementation and the risk of spontaneous preterm birth: a cohort study.

      Bukowski, Radek; Malone, Fergal D; Porter, Flint T; Nyberg, David A; Comstock, Christine H; Hankins, Gary D V; Eddleman, Keith; Gross, Susan J; Dugoff, Lorraine; Craigo, Sabrina D; et al. (2009-05-05)
      Low plasma folate concentrations in pregnancy are associated with preterm birth. Here we show an association between preconceptional folate supplementation and the risk of spontaneous preterm birth.
    • Role of second-trimester genetic sonography after Down syndrome screening.

      Aagaard-Tillery, Kjersti M; Malone, Fergal D; Nyberg, David A; Porter, T Flint; Cuckle, Howard S; Fuchs, Karin; Sullivan, Lisa; Comstock, Christine H; Saade, George R; Eddleman, Keith; et al. (2009-12)
      To estimate the effectiveness of second-trimester genetic sonography in modifying Down syndrome screening test results.
    • Thyroperoxidase and thyroglobulin antibodies in early pregnancy and preterm delivery.

      Haddow, James E; Cleary-Goldman, Jane; McClain, Monica R; Palomaki, Glenn E; Neveux, Louis M; Lambert-Messerlian, Geralyn; Canick, Jacob A; Malone, Fergal D; Porter, T Flint; Nyberg, David A; et al. (2010-07)
      To further evaluate the relationship between thyroid antibodies and preterm births.